Skip to content

The correlation of periodontal disease and its pathogenic bacteria with prognosis and subclinical atherosclerosis in patients with coronary heart disease

The correlation of periodontal disease and its pathogenic bacteria with prognosis and subclinical atherosclerosis in patients with coronary heart disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300079212
Enrollment
Unknown
Registered
2023-12-27
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease and Periodontal Disease

Interventions

Mild periodontal disease group/Moderate periodontal disease group/Severe periodontal disease group:None

Sponsors

the First Affiliated Hospital of Henan University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients hospitalized in the Department of Cardiology of the First Affiliated Hospital of Henan University of Science and Technology from January 2024 to June 2024 were enrolled. 2. Coronary angiography was performed to confirm the diagnosis of coronary heart disease. 3. Patients who consented to undergo carotid ultrasonography and dental examination. 4.Informed consent was obtained.

Exclusion criteria

Exclusion criteria: 1. Patients aged 65 years. 2. Patients with a previously established diagnosis of coronary artery disease. 3. Patients who had previously been diagnosed with periodontal disease and received dental intervention. 4. Patients with severe valvular disease and heart failure (NYHA class ?~?). 5. Severe renal failure (glomerular filtration rate 220mmol/L (2.5mg/dl)), or hemodialysis treatment. 6. Inability to communicate due to severe cognitive impairment or other reasons. 7. Acute myocardial infarction. 8. The expected survival time is less than 1 year (combined with malignant tumor, severe heart and lung diseases, etc.). 9. Participated in other interventional clinical studies that may have affected the assessment of outcomes. 10. Severe liver dysfunction. 11. Other conditions considered by the investigator to be inappropriate for participation in the study or likely to pose a significant risk to the patient (e.g., inability to understand and/or comply with study procedures and/or follow-up due to mental illness, cognitive or emotional disorder). 12. Patients currently taking immunosuppressive agents or undergoing immunotherapy.

Design outcomes

Primary

MeasureTime frame
Major adverse cardiovascular events;

Secondary

MeasureTime frame
Periodontal disease severity;Quantification of porphyromonas gingivalis;Carotid intimedia thickness;Laboratory indexes;

Countries

China

Contacts

Public ContactYingle Wu

the First Affiliated Hospital of Henan University of Science and Technology

beautyfree@126.com+86 150 3866 8777

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026